BF-2 cells (from bluegill fry, Lepomis macrochirus; ATCC CCL-91) were used for antibody neutralizing tests. Both cell lines were grown in MEM (Gibco) culture medium supplemented with penicillin (100 IU ml−1), streptomycin (100 μg ml−1) and 10% FCS at 20 °C. For the construction of the check details IPNV DNA vaccine (pIPNV-PP), the polyprotein gene was amplified by a polymerase chain reaction (PCR)

from a cDNA sample obtained from the spleen of a trout infected with IPNV Sp strain using specific primers (Table 1), containing both the start and stop codons. The PCR product was cloned into the expression vector pcDNA3.1/V5-His-TOPO according to manufacturer’s instructions (Invitrogen) and used to transform One Shot TOP10 Escherichia coli cells (Invitrogen). A clone containing the pIPNV-PP was identified by PCR screening, and the proper orientation was verified by sequencing. A religated empty pcDNA3.1/V5-His-TOPO plasmid (pcDNA3.1) was used as a negative control. The pMCV1.4-G plasmid used as a VHSV DNA vaccine consisted of the gene encoding the glycoprotein

G of VHSV Selleckchem BLZ945 under the control of the long cytomegalovirus (CMV) promoter, previously described [22]. The effectiveness of this VHSV vaccine has been previously demonstrated [23] and [24]. The empty vector (pMCV1.4) was used as a control. To ensure that cloned polyprotein gene could express protein in vitro, the pIPNV-PP plasmid was used as template in the transcend non-radioactive transcription/translation quick coupled system (Promega), which allows a biotinylated detection of proteins synthesized in vitro. The viral protein(s) expressed were separated on a SDS-polyacrylamide Non-specific serine/threonine protein kinase gel electrophoresis, transferred to nitrocellulose membranes and the biotinylated proteins visualized by binding streptavidin–horsedish peroxidase, followed by colorimetric detection. Confluent cultures of actively growing EPC cells were trypsined and dispensed into 24-well plates

at a concentration of 6 × 105 cells ml−1. After 24 h of incubation at 28 °C, cells were transfected by the addition of 3 μl of Fugene 6 (Roche) complexed with either 0.5 μg of pIPNV-PP or the empty plasmid (control). After a further 72 h of incubation at 28 °C, cells were trypsined and processed for RNA isolation or electron microscopy. Expression of the plasmid by the EPC cells was confirmed by VP2 gene expression by semi-quantitative PCR whilst induction of the EPC-antiviral Mx gene was evaluated by real-time PCR (see below). For electron microscopy, cells were fixed in 1% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) for 2 h at 4 °C, then postfixed in 1% osmium tetroxide in 0.1 M cacodylate buffer (pH 7.2) for 1 h at 4 °C and embedded in Epon. Ultrathin sections were obtained with a Reichert-Jung ultramicrotome, contrasted with uranyl acetate and lead citrate and examined with a Zeiss EM 10C electron microscope.